71837-5843 : Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution


NDC: 71837-5843
Labeler: Partner Therapeutics, Inc
Product Type: Human Prescription Drug
Drug Name:  Leukine
Dosage Form: Intravenous; Subcutaneous Injection, Powder, for Solution
Application #: BLA103362
Rev. Date: 


NDC Package Codes:

  • 71837-5843-5: 5 VIAL IN 1 CARTON (71837‑5843‑5) > 1 ML IN 1 VIAL

Active Ingredients:

  • Sargramostim

Dosage Strength:

  • 250 ug/mL

Pharmaceutical Classes:

  • Granulocyte Colony-Stimulating Factor [CS]
  • Granulocyte-Macrophage Colony-Stimulating Factor [CS]
  • Increased Myeloid Cell Production [PE]
  • Leukocyte Growth Factor [EPC]

Related Products:

Based on records with the same trade name.
  • 71837-5844 Leukine 500 ug/ml Intravenous; Subcutaneous Liquid by Partner Therapeutics, Inc
  • 0024-5843 Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution by Sanofi-aventis U.S. LLC
  • 0024-5844 Leukine 500 ug/ml Intravenous; Subcutaneous Liquid by Sanofi-aventis U.S. LLC
  • 58468-0180 Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution by Genzyme Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71837-5843 QR Code

< Prev: 71834-075Next: 71837-5844 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.